Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Ana Rita Pedrosa"'
Autor:
Rogério Ferreira, Ana Rita Pedrosa, Neuza Reis, Luís Sousa, Célia Nicolau, Bruno Ferreira, Belmiro Rocha, Cristina Lavareda Baixinho
Publikováno v:
BMC Nursing, Vol 23, Iss 1, Pp 1-12 (2024)
Abstract Background The literature review notes that people in need of care from Rehabilitation Programs do not always see their continuity ensured. Objective This study aim to analyze the perspective of Specialists Nurse in Rehabilitation Nursing in
Externí odkaz:
https://doaj.org/article/b81a58ed36af439994dbfe4c8663360c
Autor:
Tanguy Lechertier, Louise E. Reynolds, Hyojin Kim, Ana Rita Pedrosa, Jesús Gómez-Escudero, José M. Muñoz-Félix, Silvia Batista, Matthew Dukinfield, Fevzi Demircioglu, Ping Pui Wong, Kylie P. Matchett, Neil C. Henderson, Gabriela D’Amico, Maddy Parsons, Catherine Harwood, Pascal Meier, Kairbaan M. Hodivala-Dilke
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/33e6176c6d6a4fc595fff02b19cc1f2f
Autor:
Tanguy Lechertier, Louise E. Reynolds, Hyojin Kim, Ana Rita Pedrosa, Jesús Gómez-Escudero, José M. Muñoz-Félix, Silvia Batista, Matthew Dukinfield, Fevzi Demircioglu, Ping Pui Wong, Kylie P. Matchett, Neil C. Henderson, Gabriela D’Amico, Maddy Parsons, Catherine Harwood, Pascal Meier, Kairbaan M. Hodivala-Dilke
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
Abstract The overexpression of the protein tyrosine kinase, Focal adhesion kinase (FAK), in endothelial cells has implicated its requirement in angiogenesis and tumour growth, but how pericyte FAK regulates tumour angiogenesis is unknown. We show tha
Externí odkaz:
https://doaj.org/article/327b0c1e155a4263840ab94acda7cb38
Publikováno v:
EMBO Molecular Medicine, Vol 12, Iss 2, Pp 1-2 (2019)
Abstract Pathological angiogenesis contributes to tumour progression as well as to chronic inflammatory diseases. In this issue of EMBO Molecular Medicine, Esteban and co‐workers identify endothelial cell MT1‐MMP as a key regulator of intussuscep
Externí odkaz:
https://doaj.org/article/3acbc696ba2e4167ac0ce71b2c4c8860
Autor:
Frances R. Balkwill, Eleni Maniati, Florian Laforets, Ana-Rita Pedrosa, Colin Pegrum, Ludmila Szabova, Anissa Lakhani, Chiara Berlato, Ganga Gopinathan
Supplementary Figure from Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::021efd7459fd452996c812e5f5d79de2
https://doi.org/10.1158/1535-7163.22522996.v1
https://doi.org/10.1158/1535-7163.22522996.v1
Autor:
Frances R. Balkwill, Eleni Maniati, Florian Laforets, Ana-Rita Pedrosa, Colin Pegrum, Ludmila Szabova, Anissa Lakhani, Chiara Berlato, Ganga Gopinathan
Supplementary Table from Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34d4fb065eea61680e82e1482f66b7bc
https://doi.org/10.1158/1535-7163.22522993
https://doi.org/10.1158/1535-7163.22522993
Autor:
Frances R. Balkwill, Eleni Maniati, Florian Laforets, Ana-Rita Pedrosa, Colin Pegrum, Ludmila Szabova, Anissa Lakhani, Chiara Berlato, Ganga Gopinathan
This article investigates mechanisms of resistance to the VEGF receptor inhibitor cediranib in high-grade serous ovarian cancer (HGSOC), and defines rational combination therapies. We used three different syngeneic orthotopic mouse HGSOC models that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee8b0a606bafd5dbbe6c73a913e75eb
https://doi.org/10.1158/1535-7163.c.6543544.v1
https://doi.org/10.1158/1535-7163.c.6543544.v1
Autor:
Kairbaan M. Hodivala-Dilke, Thomas Iskratsch, Maddy Parsons, Bryan Serrels, Bernardo Tavora, Silvia Batista, Annika N. Alexopoulou, Vassiliki Kostourou, Delphine M. Lees, Isabelle Fernandez, Paraskivi Natalia Georgiou, Louise E. Reynolds, Edward P. Carter, Jesus Gomez-Escudero, Natalia Bodrug, Ana-Rita Pedrosa
Supplementary Figure 1 and 2. Generation and Characterisation of ECCre+;FAKY397F/Y397F and ECCre+;FAKY861F/Y861F mice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5282133926484d2f37715e73d3989246
https://doi.org/10.1158/0008-5472.22422237.v1
https://doi.org/10.1158/0008-5472.22422237.v1
Autor:
Kairbaan M. Hodivala-Dilke, Thomas Iskratsch, Maddy Parsons, Bryan Serrels, Bernardo Tavora, Silvia Batista, Annika N. Alexopoulou, Vassiliki Kostourou, Delphine M. Lees, Isabelle Fernandez, Paraskivi Natalia Georgiou, Louise E. Reynolds, Edward P. Carter, Jesus Gomez-Escudero, Natalia Bodrug, Ana-Rita Pedrosa
Supplementary Figure 6. Knocking down Ang-2 in B16F0s cells ablates angiogenic response in ECCre+;FAKY861F/Y861F mice in vivo.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28ed9c4100bd25c2f70043fe68231339
https://doi.org/10.1158/0008-5472.22422225.v1
https://doi.org/10.1158/0008-5472.22422225.v1
Autor:
Kairbaan M. Hodivala-Dilke, Thomas Iskratsch, Maddy Parsons, Bryan Serrels, Bernardo Tavora, Silvia Batista, Annika N. Alexopoulou, Vassiliki Kostourou, Delphine M. Lees, Isabelle Fernandez, Paraskivi Natalia Georgiou, Louise E. Reynolds, Edward P. Carter, Jesus Gomez-Escudero, Natalia Bodrug, Ana-Rita Pedrosa
Expression of focal adhesion kinase (FAK) in endothelial cells (EC) is essential for angiogenesis, but how FAK phosphorylation at tyrosine-(Y)397 and Y861 regulate tumor angiogenesis in vivo is unknown. Here, we show that tumor growth and angiogenesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1eee9a002e76a2569618268b1a0af530
https://doi.org/10.1158/0008-5472.c.6511158.v1
https://doi.org/10.1158/0008-5472.c.6511158.v1